Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kasper

Showing results (381-390 of 419) with videos related to

Pageof 42
Sort By:
Journal of Personalized Medicine|February 20, 2015
Common genetic risk for melanoma encourages preventive behavior changeLori Diseati, Laura B Scheinfeldt, Rachel S Kasper, et al.
Journal of Cancer Research and Clinical Oncology|August 26, 2020
Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapyM Markus, A Abendroth, R Noureddine, et al.
The International Journal of Neuropsychopharmacology|March 5, 2021
The Influence of Acute SSRI Administration on White Matter Microstructure in Patients Suffering From Major Depressive Disorder and Healthy ControlsR Seiger, G Gryglewski, M Klöbl, et al.
Leukemia|March 20, 2013
A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signalingA Caldarelli, J P Müller, M Paskowski-Rogacz, et al.
Molecular Psychiatry|November 1, 2003
A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorderM Willeit, N Praschak-Rieder, A Neumeister, et al.
NMR in Biomedicine|February 23, 2022
7 tricks for 7 T CEST: Improving the reproducibility of multipool evaluation provides insights into the effects of age and the early stages of Parkinson's diseaseAngelika Mennecke, Katrin M Khakzar, Alexander German, et al.
The Pharmacogenomics Journal|April 9, 2014
PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathwayC Fabbri, A Marsano, D Albani, et al.
Fortschritte Der Neurologie-Psychiatrie|April 12, 2007
[Clinical standing of valproate treatment of bipolar disorders]H Grunze, M Adli, M Bauer, et al.
Mucosal Immunology|December 11, 2014
PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosisM R Spalinger, S Kasper, C Chassard, et al.
Neuropsychobiology|November 28, 2000
Association studies of candidate genes in bipolar disordersA Heiden, P Schüssler, U Itzlinger, et al.
Pageof 42

Showing results (381-390 of 419) with videos related to

Sort By:
Pageof 42
Journal of Personalized Medicine|February 20, 2015
Common genetic risk for melanoma encourages preventive behavior changeLori Diseati, Laura B Scheinfeldt, Rachel S Kasper, et al.
Journal of Cancer Research and Clinical Oncology|August 26, 2020
Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapyM Markus, A Abendroth, R Noureddine, et al.
The International Journal of Neuropsychopharmacology|March 5, 2021
The Influence of Acute SSRI Administration on White Matter Microstructure in Patients Suffering From Major Depressive Disorder and Healthy ControlsR Seiger, G Gryglewski, M Klöbl, et al.
Leukemia|March 20, 2013
A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signalingA Caldarelli, J P Müller, M Paskowski-Rogacz, et al.
Molecular Psychiatry|November 1, 2003
A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorderM Willeit, N Praschak-Rieder, A Neumeister, et al.
NMR in Biomedicine|February 23, 2022
7 tricks for 7 T CEST: Improving the reproducibility of multipool evaluation provides insights into the effects of age and the early stages of Parkinson's diseaseAngelika Mennecke, Katrin M Khakzar, Alexander German, et al.
The Pharmacogenomics Journal|April 9, 2014
PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathwayC Fabbri, A Marsano, D Albani, et al.
Fortschritte Der Neurologie-Psychiatrie|April 12, 2007
[Clinical standing of valproate treatment of bipolar disorders]H Grunze, M Adli, M Bauer, et al.
Mucosal Immunology|December 11, 2014
PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosisM R Spalinger, S Kasper, C Chassard, et al.
Neuropsychobiology|November 28, 2000
Association studies of candidate genes in bipolar disordersA Heiden, P Schüssler, U Itzlinger, et al.
Pageof 42